natgillin/translations-raw huggingface dataset:
Synk tabletten hel sammen med et glas vand.
Swallow the tablet without chewing, with a glass of water.
Synk tabletten hel sammen med vand.
Swallow the tablet whole, with some water.
Synk tabletten hel – lad være med at tygge den, knuse den eller opløse den i munden.
Swallow your tablet whole — do not chew it, crush it or let it dissolve in your mouth.
Synk tabletten hel – lad være med at tygge den, knuse den eller opløse den i munden.
Swallow your tablet whole, do not chew it, crush it or let it dissolve in your mouth.
Synk tabletten med et helt glas vand (mindst 180 ml).
Swallow your tablet with a full glass of water (at least 180 ml).
Synk tabletten med væske som f.eks. vand eller mælk.
Swallow the tablet with a drink such as water or milk.
Synk tabletterne hele med et glas vand
Swallow your tablets whole with a glass of water.
Synk tabletterne hele med et glas vand.
Swallow the tablets whole with a glass of liquid.
Synk tabletterne hele med et stort glas vand.
Swallow the tablets whole with a large glass of water.
Synk tabletterne hele med lidt vand.
Swallow the tablets whole with some water.
Synk tabletterne hele med vand.
Swallow them whole with water.
Synk tabletterne hele og drik samtidig et glas vand.
Swallow the tablets whole with a glass of water.
Synk tabletterne hele sammen med vand.
Swallow the tablet whole with water.
Synk tabletterne hele, én efter én, sammen med vand på samme tidspunkt hver dag.
Swallow the tablets whole with water, one after the other, at the same time each day.
Synk tabletterne hele.
Swallow tablets whole.
Synk tabletterne med vand.
Swallow the tablets with some water.
Synk tabletterne med væske som f.eks. vand eller mælk.
Swallow the tablets with a drink such as water or milk.
Synk tablettten hel.
Swallow the tablet whole.
Synk væsken fra sprøjten eller fastgør sprøjten til en gastrostomisonde eller nasogastrisk sonde.
Swallow the liquid from the oral syringe or attach the oral syringe to a gastrostomy or nasogastric tube.
synkebesvær
difficulty swallowing
Synkebesvær
Difficulty to swallow
Synkebesvær
Difficulty with swallowing
Synkebesvær (dysfagi)
Difficulty in swallowing (dysphagia)
Synkebesvær eller besvær med at trække vejret
Trouble swallowing or breathing
Synkebesvær eller smerter ved synkning
difficulty or painful swallowing
Synkebesvær eller smerter ved synkning Blødninger
difficulty or painful swallowing
synkebesvær,
difficulty swallowing,
Synkebesvær.
Difficulty swallowing.
Synkes hele  må ikke tygges, deles eller knuses.
Swallow whole, do not chew, divide or crush.
synkevanskeligheder
wallowing disorders
Synkope (3%)
Syncope (3%)
Synkope (G3/4: 0 %)
Syncope (G3/4: 0%);
Synkope (G3/4: 0 %) Neurotoksicitet (G3/4: 0 %);
Syncope (G3/4: 0%); Neurotoxicity (G3/4: 0%);
Synkope (G3/4: 0 %);
Syncope (G3/4: 0%);
Synkope (G3/4: 0 %); neurotoksicitet (G3/4: 0
Syncope (G3/4: 0%);
Synkope (G3/4: 0%); Neurotoksicitet (G3/4: 0%);
Syncope (G3/4: 0%) Neurotoxicity (G3/4: 0%);
Synkope Bevidst- løshed1
Syncope Loss of consciousness1
Synkope eller vasovagalt anfald i forbindelse med injektion, lokaliseret hypæstesi
Syncope or vasovagal responses to injection, localised hypoaesthesia
synkope er set efter samtidig
concerning co-administration with
Synkope Kramper Amnesi
Syncope Seizure Amnesia
Synkope Manglende reaktion Tab af bevidsthed
Syncope Unresponsiveness Loss of consciousness
synkope, cerebrovaskulært attak, øget forekomst af tegn og symptomer på myasthenia gravis, paræstesi, cerebral iskæmi
syncope, cerebrovascular accident, increase in signs and symptoms of myasthenia gravis, paraesthesia, cerebral ischaemia
synkope, hovedpine,
syncope, headache
Synkope, hovedpine, svimmelhed1.
Syncope, headache, dizziness1.
synkope, hukommelsessvækkelse, opmærksomhedsforstyrr else, drømmende sindstilstand, uro i benene (restless legs syndrome), dårlig søvnkvalitet, paræstesier
Syncope, memory impairment, disturbance in attention, dreamy state, restless legs syndrome, poor quality sleep, paraesthesia
synkope, hypertension, venøs tromboemboli (inklusive lungeemboli og dyb venetrombose)
syncope, hypertension, venous thromboembolism (including pulmonary embolism and deep vein thrombosis)
synkope, krampe, ageusi, forstyrrelser i søvnfaserytmen
syncope, convulsion, ageusia, sleep phase rhythm disturbance
Synkope, tremor, paræstesi
Syncope, Tremor Paraesthesia
Synkope1,4
Syncope1,4
Synkope2
Uncommon
Synkope2 Hypertension3,
Syncope2
Synkope2 Hypertension3,7
Syncope2 Hypertension3,7
Synkope2 Øget blodtryk3
Syncope2
Synkope2 Øget blodtryk3
Syncope2 Blood pressure increase3
Synlig gul indikator
Yellow Indicator Visible
Synlige hævelser i ansigt, hænder, ben, fødder eller ankler (perifert ødem)
Visible swelling of the face, hands, legs, feet or ankles (peripheral oedema)
synligt, så har De
you have
Synperonic NCA 830 Dimethylsulfoxid Gamma-hexalacton
Synperonic NCA 830 Dimethyl sulfoxide Gamma-hexalactone
Syns- eller høreforstyrrelser
Problems with your sight or hearing
Synsfarve-
Visual colour
Synsfarve- forvrængning**, synsforstyrrelser,
Visual colour distortions**, Visual disturbance, Vision blurred
Synsfeltdefekt, sløret syn, dobbeltsyn
Visual field defect, vision blurred, diplopia
Synsfeltsdefekt, Hævede øjenlåg Konjunktival hyperæmi, Non- arteritis anterior iskæmisk optikusneuropati (NAION)2,
Visual field defect, Swelling of eyelids, Conjunctival hyperaemia, Non- arteritic anterior
Synsfeltsdefekt, Hævede øjenlåg, Konjunktival hyperæmi,
Visual field defect, Swelling of eyelids, Conjunctival hyperaemia,
Synsforbedringen var fulgt af en reduktion i central retinal tykkelse.
The improvement of vision was accompanied by a reduction in central retinal thickness.
Synsforstyr- relser
Visual impairment
Synsforstyr- relser/okulære hændelser#
Vision disorders/Ocular events#
Synsforstyrrelse
Visual disturbance
Synsforstyrrelse*
Visual disturbance
Synsforstyrrelser
Disturbance of vision
Synsforstyrrelser
Eye disorders
Synsforstyrrelser
Vision disorder
Synsforstyrrelser
Vision disturbances
Synsforstyrrelser
Visual disturbance Ocular hyperemia
Synsforstyrrelser (aura).
Halo vision.
Synsforstyrrelser (diplopi, halo-syn, fotofobi, fotopsi, sløret syn, nedsat synsskarphed, visuel lysintensitet, nedsat syn, visuel perseveration, ”flyvende fluer”).
Vision disorder (Diplopia, Halo vision, Photophobia, Photopsia, Vision blurred, Visual acuity reduced, Visual brightness, Visual impairment, Visual perseveration, Vitreous floaters).
Synsforstyrrelser (inklusive dobbeltsyn)am
Visual disturbance (including diplopia)am
synsforstyrrelser (inklusive nedsat syn), inflammation i øje eller øjenlåg, lakrimationsforstyrrelser
visual disorder (including decreased vision), eye and eyelid inflammation, lacrimation disorder
synsforstyrrelser (inklusive synsforstyrrelser, sløret syn og nedsat syn), tørre øjne
visual disorder (including visual disturbance, vision blurred, and visual acuity reduced), dry eye
Synsforstyrrelser (lysglimt, sløret syn eller dobbeltsyn, som almindeligvis begynder lige efter behandlingen med XALKORI er påbegyndt).
Visual effects (seeing flashes of light, blurred vision, or double vision, often beginning soon after starting treatment with XALKORI).
Synsforstyrrelser (sløret syn, besvær med at se skarpt, dobbeltsyn) (læs venligst punkt 2)
visual disturbances (blurred vision, difficulty in focusing, double vision)(please read section 2)
Synsforstyrrelser *
Refraction disorder
Synsforstyrrelser omfatter bivirkninger i form af tågesyn, diplopi, fotopsi, nedsat visuel akuitet og blindhed
Vision disorder includes adverse reactions of blurred vision, diplopia, photopsia, reduced visual acuity, and blindness;
Synsforstyrrelser på grund af hævelse (eller væske) bagest i øjet (hyppigheden kan ikke vurderes ud fra de tilgængelige data) er ligeledes blevet indberettet hos patienter, der tager Actos.
Blurred vision due to swelling (or fluid) at the back of the eye (frequency cannot be estimated from the available data) has also been reported in patients taking Actos.
Synsforstyrrelser på grund af hævelse (eller væske) bagest i øjet (hyppigheden kan ikke vurderes ud fra de tilgængelige data) er ligeledes blevet indberettet hos patienter, der tager Glustin.
Blurred vision due to swelling (or fluid) at the back of the eye (frequency cannot be estimated from the available data) has also been reported in patients taking Glustin.
Synsforstyrrelser såsom sløret syn eller dobbeltsyn.
Problems with sight such as blurred or double vision.
Synsforstyrrelser*
Refraction disorder
Synsforstyrrelser*
Vision abnormal
Synsforstyrrelser, misfarvning i øjenæblet, forstørrede pupiller, lysfølsomhed, nærsynethed, øjne der løber i vand
Disturbed vision, eyeball discolouration, dilated pupils, sensitivity to light, shortsightedness, watery eyes
Synsforstyrrelser, oscillopsi, forstyrrelser i binokulært syn, okulær hyperæmi, saccadiske øjenbevægelser,
Vision disturbance, oscillopsia, binocular eye movement disorder, ocular hyperaemia, saccadic eye
Synsforstyrrelser, sløret syn, øjenirritation, smerter eller hævelse, øget følsomhed over for lys (fotofobi)
Visual disturbances, blurred vision, eye irritation, pain or swelling, increased sensitivity to light (photophobia)
Synsforstyrrelser, Tørre øjne, Øjensmerter, Synsnedsættelse, Sløret syn
Visual disorders, Dry eye, Eye pain, Visual impairment, Vision blurred
Synsforstyrrelser, usædvanlige øjenbevægelser, ændring i synet herunder tunnelsyn, lysglimt, urolige bevægelser, nedsatte reflekser, øget aktivitet, svimmelhed i stående stilling, følsom hud, manglende smagsevne, brændende fornemmelse, rysten ved bevægelse, nedsat bevidsthed, bevidshedstab, besvimelse, øget følsomhed over for støj, utilpashed.
Changes in eyesight, unusual eye movement, changes in vision including tunnel vision, flashes of light, jerky movements, reduced reflexes, increased activity, dizziness on standing, sensitive skin, loss of taste, burning sensation, tremor on movement, decreased consciousness, loss of consciousness, fainting, increased sensitivity to noise, feeling unwell
Synsforstyrrelser, usædvanlige øjenbevægelser, ændring i synet herunder tunnelsyn, lysglimt, urolige bevægelser, nedsatte reflekser, øget aktivitet, svimmelhed i stående stilling, følsom hud, manglende smagsevne, brændende fornemmelse, rysten ved bevægelse, nedsat bevidsthed, bevidshedstab, besvimelse, øget følsomhed over for støj, utilpashed.
Changes in eyesight, unusual eye movement, changes in vision including tunnel vision, flashes of light, jerky movements, reduced reflexes, increased activity, dizziness on standing, sensitive skin, loss of taste, burning sensation, tremor on movement, decreased consciousness, loss of consciousness, fainting, increased sensitivity to noise, feeling unwell.
Synsforstyrrelser, usædvanlige øjenbevægelser, ændring i synet herunder tunnelsyn, lysglimt, urolige bevægelser, nedsatte reflekser, øget seksuel interesse, svimmelhed i stående stilling, følsom hud, manglende smagsevne, brændende fornemmelse, rysten ved bevægelse, nedsat bevidsthed, bevidshedstab, besvimelse, øget følsomhed over for støj, utilpashed.
Changes in eyesight, unusual eye movement, changes in vision including tunnel vision, flashes of light, jerky movements, reduced reflexes, increased activity, dizziness on standing, sensitive skin, loss of taste, burning sensation, tremor on movement, decreased consciousness, loss of consciousness, fainting, increased sensitivity to noise, feeling unwell.
Synsforstyrrelser.
Visual disturbances.
Synsforstyrrelser2
visual disturbance2
Synsforstyrrelser2
with sulpho- nylurea
Synsforstyrrelser: Når du påbegynder insulinbehandling, kan du opleve synsforstyrrelser, forstyrrelsen er normalt midlertidig.
Vision problems: When you first start your insulin treatment, it may disturb your vision, but the disturbance is usually temporary.
Synsforstyrrelsera
Vision disordera
Synsforstyrrelsere (63%)
Vision disordere (63%)
Synsforstyrrelser
Abnormal vision 
synsnedsættel- se6
visual impairment6
Synsnedsættelse
Impaired vision
Synsnedsættelse
Visual impairment
Synsnedsættelse
Visual impairments
Synsnedsættelse (dobbeltsyn)
Visual impairment
Synsnedsættelse (inklusive sløret syn og forekomst af prikker/lyspletter)
Vision impairment (including blurred vision, appearance of spots/lights)
Synsnedsættelse herunder diplopi, sløret syn og nedsat synsskarphed
visual impairment including diplopia, vision blurred and visual acuity reduced
Synsnedsættelse, herunder diplopi, sløret syn og nedsat synsskarphed
visual impairment including diplopia, vision blurred and visual acuity reduced
synsnedsættelse, sløret syn
Infections and infestations
Synsnedsættelse.
Vision impairment.
Synsnedsættelsee
Visual impairmente
Synsproblemer
Vision problems
Synsproblemer på grund af blod i øjet
Visual problems caused by blood in your eye
synsproblemer som sløret syn, dobbeltsyn, nedsat syn, grå stær
vision troubles as blurred vision, double vision, decreased vision, cataracts
Synsproblemer, såsom sløret syn
Eyesight problems such as blurred vision.
Synsproblemer: Når du påbegynder insulinbehandling, kan du opleve synsforstyrrelser, men forstyrrelserne er normalt midlertidige.
Vision problems: When you first start your insulin treatment, it may disturb your vision, but the disturbance is usually temporary.
Synsrelaterede bivirkninger
Visual adverse reactions
Synssvækkelse
visual impairment
Synstab
Loss of vision
Synstab
Vision loss
Synstab hos voksne, der skyldes blokering af blodårer i øjet.
Vision loss caused by a blockage of veins in the eye.
Synstab som følge af diabetisk maculaødem (DME), hvis du er blevet opereret for grå stær, eller hvis du tidligere ikke har reageret på eller ikke er egnet til andre typer behandling.
Vision loss due to diabetic macular oedema (DME), if you have already had an operation for cataract, or if you have not previously responded to, or are not suitable for, other types of treatment.
Syntetisk GnRF peptid-analog: Auspep Clinical Peptides PTY Ltd.
Synthetic GnRF peptide analogue: Auspep Clinical Peptides PTY Ltd.
Syptomer
Symptoms
Syreblokkeren og H2 -antagonisten famotidin nedsætter absorptionshastigheden for aripiprazol, men denne virkning synes ikke klinisk relevant.
A gastric acid blocker, the H2 antagonist famotidine, reduces aripiprazole rate of absorption but this effect is deemed not clinically relevant.
Syreblokkeren og H2 antagonisten famotidin nedsætter absorptionshastigheden for Aripiprazole, men denne virkning synes ikke klinisk relevant.
A gastric acid blocker, the H2 antagonist famotidine, reduces aripiprazole rate of absorption but this effect is deemed not clinically relevant.
SYREHÆMMENDE MIDLER
ACID REDUCING AGENTS
Syreneutraliserende lægemidler (f.eks. aluminiumhydroxid) må ikke administreres før tidligst 2 timer efter indtagelse af Ketoconazole HRA.
Acid-neutralising medicines (e.g. aluminium hydroxide) should not be administered for at least 2 hours after the intake of Ketoconazole HRA.
syreneutraliserende midler og pantoprazol (medicin til behandling af sur mave)
antacids and pantoprazole (used to treat upset stomach)
syreneutraliserende midler, anvendes til at behandle halsbrand (se også punkt 3, Sådan skal De tage Genvoya).
antacids, used to treat heartburn or acid reflux (see also section 3, How to take Genvoya).
Syrepumpehæmmere
Acid reducing agents
Syrepumpehæmmere
Ethinyl estradiol (saquinavir/ritonavir)
Syrepumpehæmmere
Proton Pump Inhibitors
Syrepumpehæmmere
Proton Pump Inhibitors:
Syrepumpehæmmere
used in study)
SYREREDUCERENDE MIDLER
ACID REDUCING AGENTS
Syreresistente mikrotabletter
Enteric-coated microtablets
Syrestoffer i blodet som følge af sukkersyge (diabetisk ketoacidose), diabetes
Acid in the blood produced from diabetes (diabetic ketoacidosis), diabetes
Syretermineret 50:50 poly D,L-lactid-co-glycolid.
Acid terminated 50:50 poly D,L-lactide-co-glycolide.
Syruppen indeholder aspartam (E951), en phenylalaninkilde, som kan være skadelig for patienter med fenylketonuri (PKU, Føllings sygdom).
The syrup contains aspartame (E951), a source of phenylalanine, which may be harmful for people with phenylketonuria.
Syste morganklasse i he nhold til MedDRA
MedDRA system organ class
system og mammae
Reproductive system and breast disorders
system og mammae
ystem and breast disorders
System- organklasse
Body System
System- organklasse
disorders and
System- organklasse
obliterans,
System- organklasse
Reproductive system and breast disorders
System- organklasse
System Organ Class
System- organklasse
y cutaneous),
System-organklasse
System organ class
Systemet er fuldt aktiveret, når der høres et "klik".
The system is fully activated when a ‘click’ is heard.
Systemet genererer dråber via ultralyd, som presser opløsningen igennem et net.
This system generates droplets by ultrasound, which is forcing the solution through a mesh.
Systemet kontrollerer ikke dit blodsukker; derfor skal du kontrollere dit blodsukker mindst 4 gange daglig svarende til metoden og hyppigheden, som din læge anbefaler;
The system does not check your blood glucose; therefore you need to check your blood glucose at least 4 times a day according to the method and frequency recommended by your physician;
Systemet sidder ikke godt nok fast
System is not securely adhered
Systemfejl
System error
Systemisk absorption af de aktive stoffer blev bestemt ved enkeltdosis-studier med [14C]-orbifloxacin, [3H]-mometasonfuroat og [14C]-posaconazol i en Posatex-formulering og placeret i øregangen på normale beaglehunde.
Systemic absorption of the active ingredients was determined in single-dose studies with [14C]- orbifloxacin, [3H]-mometasone furoate and [14C]-posaconazole contained within the Posatex formulation and placed into the ear canals of normal Beagle dogs.
Systemisk administration af potente CYP3A4-hæmmere anbefales derfor ikke til patienter, der får dasatinib.
Therefore, in patients receiving dasatinib, systemic administration of a potent CYP3A4 inhibitor is not recommended.
Systemisk allergi er sjælden ( 1/10.000 til < 1/1.000).
Systemic allergy is rare ( 1/10,000 to <1/1,000).
Systemisk allergi er sjælden ( 1/10.000 til <1/1.000).
Systemic allergy is rare ( 1/10,000 to <1/1,000).
Systemisk clearance af saquinavir var høj, 1,14 l/h/kg (CV 12 %), lidt over leverens plasma- gennemstrømning og konstant efter intravenøse doser på 6, 36 og 72 mg.
Systemic clearance of saquinavir was high, 1.14 l/h/kg (CV 12 %), slightly above the hepatic plasma flow, and constant after intravenous doses of 6, 36 and 72 mg.
systemisk dexamethason
Systemic dexamethasone
Systemisk eksponering af indacaterol øgedes med stigende (leveret) dosis (120 µg til 480 µg) og var dosisproportional.
Systemic exposure to indacaterol increased with increasing (delivered) dose (120 µg to 480 µg) in a dose proportional manner.
Systemisk eksponering efter en enkelt dosis sunitinib var den samme hos patienter med alvorligt nedsat nyrefunktion (kreatininclearance <30 ml/min) som hos personer med normal nyrefunktion (kreatininclearance >80 ml/min).
Systemic exposures after a single dose of sunitinib were similar in subjects with severe renal impairment (CLcr <30 ml/min) compared to subjects with normal renal function (CLcr >80 ml/min).
Systemisk eksponering for ceritinib stiger, når det administreres samtidig med mad.
Systemic exposure to ceritinib is increased when administered with food.
Systemisk eksponering for regorafenib ved steady state stiger proportionalt med dosen op til 60 mg og mindre end proportionalt ved doser, der er større end 60 mg.
Systemic exposure of regorafenib at steady-state increases dose proportionally up to 60 mg and less than proportionally at doses greater than 60 mg.
Systemisk emboli
Systemic embolism
Systemisk indgivne binyrebarkhormoner kan forårsage unormalt høj urinproduktion, øget tørst og øget fødeindtag, navnlig tidligt i behandlingen.
Systemically administered corticosteroids may cause polyuria, polydipsia and polyphagia, particularly during the early stages of therapy.
Systemisk indgivne kortikosteroider kan forårsage polyuri, polydipsi og polyfagi, navnlig tidligt i behandlingen.
Systemically administered corticosteroids may cause polyuria, polydipsia and polyphagia, particularly during the early stages of therapy.
Systemisk infektion eller sepsis
Systemic infection or sepsis
Systemisk inflammatorisk responssyndrom (SIRS)
Systemic Inflammatory Response Syndrome (SIRS)
Systemisk inflammatorisk responssyndrom (SIRS) eller kapillær lækage-syndrom
Systemic inflammatory response syndrome (SIRS) or capillary leak syndrome
Systemisk inflammatorisk sygdom med neonatal debut (NOMID) også kaldet kronisk infantil neurologisk hud- og ledsyndrom (CINCA)
Neonatal-Onset Multisystem Inflammatory Disease (NOMID), also called Chronic Infantile Neurological, Cutaneous, Articular Syndrome (CINCA),
Systemisk inflammatorisk sygdom med neonatal debut (NOMID) også kaldet kronisk infantil neurologisk hud- og ledsyndrom (CINCA),
Neonatal-Onset Multisystem Inflammatory Disease (NOMID), also called Chronic Infantile Neurological, Cutaneous, Articular Syndrome (CINCA),
Systemisk lidocain
Systemic lidocaine
Systemisk lupus erythematose, vaskulitis, reumatoid arthritis (ny eller forværret), Vogt-Koyanagi-Harada syndrom, akutte overfølsomhedsreaktioner inklusive nældefeber, angioødem, bronkokonstriktion, anafylakse§
Systemic lupus erythematosus, vasculitis, rheumatoid arthritis (new or aggravated), Vogt-Koyanagi-Harada syndrome, acute hypersensitivity reactions including urticaria, angioedema, bronchoconstriction, anaphylaxis§
Systemisk lupus erythematosus (SLE).
Systemic lupus erythematosus (SLE).
systemisk lupus erythematosus, angioødem, lægemiddel-allergi, sæsonbestemt allergi
ystemic lupus erythematosus, angioedema, drug hypersensitivity, seasonal allergy
systemisk lupus erythematosus, muskelsvaghed, arthritis
systemic lupus erythematosus, muscle weakness, arthritis
Systemisk lupus erythematosus, vaskulitis, reumatoid artritis (ny eller forværret), Vogt-Koyanagi-Harada syndrom, akutte overfølsomhedsreaktioner inklusive urticaria, angioødem, bronkokonstriktion, anafylakse§
Systemic lupus erythematosus, vasculitis, rheumatoid arthritis (new or aggravated), Vogt-Koyanagi-Harada syndrome, acute hypersensitivity reactions including urticaria, angioedema, bronchoconstriction, anaphylaxis§
Systemisk vaskulær modstand (-276 dyn*sek/cm5 (16%)) blev forbedret efter 12 ugers behandling.
Systemic vascular resistance (-276 dynes*sec/cm5 (16%)) was improved after 12 weeks of treatment.
systemiske
Systemic
Systemiske allergiske reaktioner, herunder anafylaksi
systemic allergic reactions including anaphylaxis
Systemiske allergiske reaktioner, herunder angioødem, urticaria, lokalt og generaliseret udslæt, pruritus, anafylaksi
Systemic allergic reactions including angioedema, urticaria, localized and generalized rash, pruritus, anaphylaxis.
Systemiske bivirkninger forårsaget af kortikosteroider, herunder Cushings syndrom og binyrebarksuppression (i ovennævnte studie blev der registreret fald i plasmakortisolniveauer på 86 %), er rapporteret hos patienter, der får ritonavir og inhaleret eller intranasal fluticasonpropionat; lignende virkninger kan også forekomme med andre kortikosteroider, som metaboliseres via CYP3A, f.eks. budesonid.
Systemic corticosteroid effects including Cushing's syndrome and adrenal suppression (plasma cortisol levels were noted to be decreased 86% in the above study) have been reported in patients receiving ritonavir and inhaled or intranasal fluticasone propionate; similar effects could also occur with other corticosteroids metabolised by CYP3A e.g., budesonide.
Systemiske bivirkninger forårsaget af kortikosteroider, herunder Cushings syndrom og binyrebarksuppression (i ovennævnte studieblev der registreret fald i plasmakortisolniveauer på 86 %), er rapporteret hos patienter, der får ritonavir og inhaleret eller intranasal fluticasonpropionat; lignende virkninger kan også forekomme med andre kortikosteroider, som metaboliseres via CYP3A, f.eks. budesonid.
Systemic corticosteroid effects including Cushing's syndrome and adrenal suppression (plasma cortisol levels were noted to be decreased 86% in the above study) have been reported in patients receiving ritonavir and inhaled or intranasal fluticasone propionate; similar effects could also occur with other corticosteroids metabolised by CYP3A eg, budesonide.